Salisbury Foundation Trust

FOI_7926

Internal Reference Number: FOI_7926

Date Request Received: 09/05/2024 00:00:00

Date Request Replied To: 29/05/2024 00:00:00

This response was sent via: By Email

Request Summary: Intra-vitreal injections or implants

Request Category: Companies



 
Question Number 1:
How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2024:

• Aflibercept

• Bevacizumab - Avastin

• Bevacizumab - Biosimilar

• Brolucizumab

• Dexamethasone

• Faricimab

• Fluocinolone acetonide

• Ranibizumab - Lucentis (pre-filled syringes)

• Ranibizumab - Lucentis (vials)

• Ranibizumab – Ongavia
 
Answer To Question 1:
• Aflibercept 1043

• Bevacizumab – Avastin <5

• Bevacizumab – Biosimilar 0

• Brolucizumab 0

• Dexamethasone 14

• Faricimab 736

• Fluocinolone acetonide 0

• Ranibizumab - Lucentis (pre-filled syringes) 5

• Ranibizumab - Lucentis (vials) 0

• Ranibizumab – Ongavia 0
 
Question Number 2:
Please see attached questions
 
Answer To Question 2:
See attached table.

To accompany this answer to question 2 please also see the documents listed below:

 7926 - Q2 - intra-vitreal injections or implants.pdf
Please see Attachments:
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 Salisbury NHS Foundation Trust
Trust Values